AbCellera Biologics(ABCL) - 2025 Q1 - Quarterly Results

NEWS RELEASE AbCellera Reports Q1 2025 Business Results 5/8/2025 VANCOUVER, British Columbia--(BUSINESS WIRE)-- AbCellera (Nasdaq: ABCL) today announced financial results for the first quarter of 2025. All financial information in this press release is reported in U.S. dollars, unless otherwise indicated. "After completion of a successful first quarter, we are excited to introduce ABCL635 as a potential first- in-class antibody for the non-hormonal treatment of vasomotor symptoms (hot flashes) associated wi ...